-transparent.png){kind=logo}
The metabolism of metronidazole was studied in microsomes isolated from livers of human kidney donors. The formation of the major in vivo metabolite, hydroxymetronidazole, proceeded according to biphasic kinetics, suggesting the involvement of at least two enzymatic sites. The affinity constant (Km) of the high affinity site ranged from 140 to 320 microM and metabolism at this site contributed more than 75% of the intrinsic clearance. Thus, at therapeutic doses of metronidazole most of the hydroxylation in vivo should be associated with this site. Antipyrine, cimetidine, alpha-naphthoflavone, caffeine, theophylline, mephenytoin, tolbutamide, quinidine, acetone and nifedipine were poor inhibitors of the formation of hydroxymetronidazole by human liver microsomes. Propranolol (500 microM) inhibited the hydroxylation rate by 70%. Phenacetin inhibited metronidazole hydroxylation with a competitive inhibition constant (Ki) of 4-5 microM. However, metronidazole did not inhibit the O-deethylation of phenacetin. It is concluded that cytochromes P450 IA2, IIC9, IIC10, IID6, IIE1 and IIIA3 do not contribute significantly to the high affinity hydroxylation of metronidazole in man.
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
March 1980,
Molecular pharmacology,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
March 2019,
Planta medica,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
May 1997,
Drug metabolism and disposition: the biological fate of chemicals,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
September 1975,
Biochemical and biophysical research communications,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
March 1988,
Cancer research,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
September 1992,
British journal of clinical pharmacology,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
December 1992,
Anesthesiology,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
August 1992,
The Clinical investigator,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
March 1982,
Xenobiotica; the fate of foreign compounds in biological systems,
S Loft, and
S V Otton, and
M S Lennard, and
G T Tucker, and
H E Poulsen
April 2006,
Toxicology and applied pharmacology,
